Repurposed drugs
New uses for approved medicines: lower cost, less time and a known safety profile.
About us
SYNERCAN develops cancer treatments that combine repurposed drugs with nanoemulsions. We start from medicines with proven safety in humans and look for combinations that act in synergy, to reach effective therapies faster and with less risk.
Our most advanced program targets osteosarcoma, one of the most common paediatric cancers and among the most resistant to chemotherapy.
New uses for approved medicines: lower cost, less time and a known safety profile.
Combinations that boost chemotherapy and allow a lower effective dose and less toxicity.
Biocompatible carriers that help the treatment reach its target more effectively.
Partners and supporters
iUIBS · ULPGC CHUIMI DISA Foundation Activa Startups